Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PL

Pierre Lafaye — 15 Patents

IPInstitut Pasteur: 15 patents #28 of 1,210Top 3%
CNCNRS: 10 patents #98 of 11,908Top 1%
CEA: 5 patents #845 of 7,956Top 15%
FAF. Hoffmann-La Roche Ag: 5 patents #45 of 425Top 15%
Paris, FR: #445 of 13,709 inventorsTop 4%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Pierre Lafaye has been granted 15 US patents while listed as an inventor at Institut Pasteur. The first was granted in 2013 and the most recent in June 2025. Pierre Lafaye ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Pierre Lafaye in Paris, FR.

Patents per Year

Patents granted per year, 2013 to 2025Bar chart with a peak of 4 patents in 2020.peak 42013: 1 patents20132016: 1 patents20162017: 1 patents20172018: 2 patents20182019: 1 patents20192020: 4 patents20202021: 2 patents20212022: 1 patents20222023: 1 patents20232025: 1 patents2025

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
12326451 Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics Sylvie Van Der Werf, Nicolas Escriou, Caroline Demeret, Stéphane Petres, Jacques Bellalou 2025-06-10
11815513 Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics Sylvie Van Der Werf, Nicolas Escriou, Caroline Demeret, Stéphane Petres, Jacques Bellalou 2023-11-14
11339211 Nanobodies suitable for neuron regeneration therapy Christophe Prehaud, Monique Lafon 2022-05-24
11124563 Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof Sylvie Bay, Benoit Delatour, Marc Dhenain, Charles Duyckaerts, Tengfei Li +3 more 2021-09-21
10948490 Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics Sylvie Van Der Werf, Nicolas Escriou, Caroline Demeret, Stéphane Petres, Jacques Bellalou 2021-03-16
10787505 Oligopeptide and methods for producing conjugates thereof Sylvie Bay, Benoit Delatour, Marc Dhenain, Charles Duyckaerts, Tengfei Li +3 more 2020-09-29
10640552 Nanobodies suitable for neuron regeneration therapy Christophe Prehaud, Monique Lafon 2020-05-05
10591466 In vitro blood-brain barrier model Christophe Prehaud, Monique Lafon, Pierre-Emmanuel Ceccaldi, Philippe Afonso 2020-03-17
10538582 Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof Sylvie Bay, Benoit Delatour, Marc Dhenain, Charles Duyckaerts, Tengfei Li +3 more 2020-01-21
10174105 Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications Francois Rougeon, Jean-Pierre Bourgeois 2019-01-08
10155054 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins Jean-Pierre Bourgeois, Francois Rougeon 2018-12-18
10087245 Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof Sylvie Bay, Benoit Delatour, Marc Dhenain, Charles Duyckaerts, Tengfei Li +3 more 2018-10-02
9738712 Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof Sylvie Bay, Benoit Delatour, Marc Dhenain, Charles Duyckaerts, Tengfei Li +3 more 2017-08-22
9387260 VHH antibodies used as peptide vectors for delivering a substance of interest Francois Rougeon, Jean-Pierre Bourgeois 2016-07-12
8460888 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins Jean-Pierre Bourgeois, Francois Rougeon 2013-06-11